These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 22586208

  • 1. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
    Shanks KG, Dahn T, Behonick G, Terrell A.
    J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
    [Abstract] [Full Text] [Related]

  • 2. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J, McLaren JM, Gerostamoulos D, Beyer J.
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [Abstract] [Full Text] [Related]

  • 3. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
    Ibáñez M, Bijlsma L, van Nuijs AL, Sancho JV, Haro G, Covaci A, Hernández F.
    J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
    [Abstract] [Full Text] [Related]

  • 4. The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs.
    Marginean I, Rowe WF, Lurie IS.
    Forensic Sci Int; 2015 Apr; 249():83-91. PubMed ID: 25679986
    [Abstract] [Full Text] [Related]

  • 5. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
    Musah RA, Domin MA, Walling MA, Shepard JR.
    Rapid Commun Mass Spectrom; 2012 May 15; 26(9):1109-14. PubMed ID: 22467461
    [Abstract] [Full Text] [Related]

  • 6. Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry.
    Shanks KG, Behonick GS, Dahn T, Terrell A.
    J Anal Toxicol; 2013 Oct 15; 37(8):517-25. PubMed ID: 23946450
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S, Ferreirós N, Pütz M, Westphal F, Zimmermann R, Auwärter V.
    J Mass Spectrom; 2010 Oct 15; 45(10):1186-94. PubMed ID: 20857386
    [Abstract] [Full Text] [Related]

  • 8. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R, Arieli M, Marom E.
    Harefuah; 2011 Dec 15; 150(12):884-7, 937. PubMed ID: 22352277
    [Abstract] [Full Text] [Related]

  • 9. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL, Gerona RR, Horowitz BZ, Vian KP, Troxell ML, Hendrickson RG, Houghton DC, Rozansky D, Su SW, Leman RF.
    Clin Toxicol (Phila); 2014 Aug 15; 52(7):664-73. PubMed ID: 25089722
    [Abstract] [Full Text] [Related]

  • 10. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid.
    Strano-Rossi S, Anzillotti L, Castrignanò E, Romolo FS, Chiarotti M.
    J Chromatogr A; 2012 Oct 05; 1258():37-42. PubMed ID: 22939380
    [Abstract] [Full Text] [Related]

  • 11. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
    Kneisel S, Auwärter V.
    J Mass Spectrom; 2012 Jul 05; 47(7):825-35. PubMed ID: 22791249
    [Abstract] [Full Text] [Related]

  • 12. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
    Musah RA, Domin MA, Cody RB, Lesiak AD, Dane AJ, Shepard JR.
    Rapid Commun Mass Spectrom; 2012 Oct 15; 26(19):2335-42. PubMed ID: 22956326
    [Abstract] [Full Text] [Related]

  • 13. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F, Asirdizer M, Aker RG, Korkut S, Gocer Y, Kucukibrahimoglu EE, Ince CH.
    J Forensic Leg Med; 2013 Aug 15; 20(6):667-72. PubMed ID: 23910858
    [Abstract] [Full Text] [Related]

  • 14. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
    Oiestad EL, Johansen U, Christophersen AS, Karinen R.
    Bioanalysis; 2013 Sep 15; 5(18):2257-68. PubMed ID: 24053241
    [Abstract] [Full Text] [Related]

  • 15. Designer drugs: a medicinal chemistry perspective.
    Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA.
    Ann N Y Acad Sci; 2012 Feb 15; 1248():18-38. PubMed ID: 22092008
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples.
    Salomone A, Gerace E, D'Urso F, Di Corcia D, Vincenti M.
    J Mass Spectrom; 2012 May 15; 47(5):604-10. PubMed ID: 22576873
    [Abstract] [Full Text] [Related]

  • 17. Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.
    Gottardo R, Chiarini A, Dal Prà I, Seri C, Rimondo C, Serpelloni G, Armato U, Tagliaro F.
    J Mass Spectrom; 2012 Jan 15; 47(1):141-6. PubMed ID: 22282100
    [Abstract] [Full Text] [Related]

  • 18. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
    Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y.
    Forensic Sci Int; 2010 May 20; 198(1-3):31-8. PubMed ID: 20117892
    [Abstract] [Full Text] [Related]

  • 19. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
    Seely KA, Patton AL, Moran CL, Womack ML, Prather PL, Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH, McCain KR, James LP, Moran JH.
    Forensic Sci Int; 2013 Dec 10; 233(1-3):416-22. PubMed ID: 24314548
    [Abstract] [Full Text] [Related]

  • 20. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
    Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y.
    Forensic Sci Int; 2014 Oct 10; 243():1-13. PubMed ID: 24769262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.